Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Vertex Pharmaceuticals (Europe) Limited .
Filed returns
14
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2025 | Vertex Pharmaceuticals (Europe) Limited | Health | Meeting to discuss cystic fibrosis in Ireland and access to medicines for CF (Public policy or programme) | 19 | On lobbying.ie |
| Jan–Apr 2024 | Vertex Pharmaceuticals (Europe) Limited | Health | Access to cystic fibrosis treatments in Ireland (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2023 | Vertex Pharmaceuticals (Europe) Limited | Health | Meeting to discuss access to cystic fibrosis medicines in Ireland (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2023 | Vertex Pharmaceuticals (Europe) Limited | Health | Access to cystic fibrosis medicines in Ireland (Public policy or programme) | 27 | On lobbying.ie |
| Sep–Dec 2022 | Vertex Pharmaceuticals (Europe) Limited | Health | Meeting to discuss access to cystic fibrosis medicines in Ireland (Public policy or programme) | 25 | On lobbying.ie |
| May–Aug 2022 | Vertex Pharmaceuticals (Europe) Limited | Health | Meeting to discuss access to cystic fibrosis medicines in Ireland (Public policy or programme) | 35 | On lobbying.ie |
| Sep–Dec 2021 | Vertex Pharmaceuticals (Europe) Limited | Health | Meeting to discuss the cystic fibrosis in Ireland and access to innovative medicines in treating this and other serious diseases (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2021 | Vertex Pharmaceuticals (Europe) Limited | Health | Meeting to discuss the cystic fibrosis in Ireland and access to innovative medicines in treating this and other serious diseases (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Vertex Pharmaceuticals (Europe) Limited | Health | Cystic Fibrosis landscape in Ireland (Matters involving public funds) | 15 | On lobbying.ie |
| May–Aug 2020 | Vertex Pharmaceuticals (Europe) Limited | Health | National Plan for Rare Diseases (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2019 | Vertex Pharmaceuticals (Europe) Limited | Health | Cystic Fibrosis landscape in Ireland (Matters involving public funds) | 18 | On lobbying.ie |
| May–Aug 2018 | Vertex Pharmaceuticals (Europe) Limited | Health | Discussion on national policies for Rare Diseases (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2017 | Vertex Pharmaceuticals (Europe) Limited | Health | HSE Reimbursement Policy (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2016 | Vertex Pharmaceuticals (Europe) Limited | Health | HSE Reimbursement Policy (Public policy or programme) | 19 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 14 | 100.0% |